VRTX

VERTEX PHARMACEUTICALS INC

Healthcare • USA

Apr 05 • 04:00PM ET
438.65
4.27 (0.98%)

Company Description

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of si... read more

State

MA

Name VERTEX PHARMACEUTICALS INC
Sector Healthcare
Currency USD
FULL TEST - ASSETS 22240200000.0
Market Cap 121877
Company Profile

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of si... read more
Full Time Employees 5,400
Phone 617 341 6100
Website https://www.vrtx.com
CEO Dr. Reshma Kewalramani FASN, M.D.
IPO Date 1991-07-24
Sector Healthcare
Address 50 Northern Avenue, Boston, MA 02210